Amyris, Inc (AMRS)

Etorro trading 970x250
Amyris, Inc (AMRS) Logo

About Amyris, Inc

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. Address: 5885 Hollis Street, EmeryVille, CA, United States, 94608

Amyris, Inc News and around…

Latest news about Amyris, Inc (AMRS) common stock and company :

Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
13 Oct, 2021 FinancialContent

If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.

Cathie Wood Goes Dumpster Diving: 3 Sagging Stocks She Just Bought
12 Oct, 2021 FinancialContent

All three of these growth stocks have been tumbling, but that doesn't frighten off ARK Invest's top stock picker.

Best Cannabis Stocks To Buy This Week? 3 To Know
11 Oct, 2021 FinancialContent
Analysts Expect 42% Gains Ahead For The Holdings of WDNA
07 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree BioRevolution Fund ETF (WDNA), we found that the implied analyst target price for the ETF based upon its underlying holdings is $35.26 per unit.

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform
05 Oct, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that Amyris has licensed the Onyx genome engineering platform from Inscripta, a leading gene editing technology company. Amyris and Inscripta will also explore joint research and development opportunities to expand the Onyx platform functionality.

7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket
04 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021. The post 7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

AMRS Makes Bullish Cross Above Critical Moving Average
01 Oct, 2021 FinancialContent

In trading on Friday, shares of Amyris Inc (AMRS) crossed above their 200 day moving average of $14.01, changing hands as high as $14.04 per share. Amyris Inc shares are currently trading up about 1.3% on the day..

Amyris Hosts Successful Fourth Webinar In Its Virtual Investor Mini-Series
01 Oct, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the fourth webinar in its virtual investor mini-series. The investor mini-series entitled "Lab-to-Market, Delivering Disruptive Health and Beauty Products" was conducted via live webcast and teleconference on Tuesday, September 28, 2021.

Commit To Buy Amyris At $5, Earn 15% Using Options
24 Sep, 2021 FinancialContent

Investors eyeing a purchase of Amyris Inc (AMRS) stock, but cautious about paying the going market price of $14.44/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2024 put at the $5 strike, which has a bid at the time of this writing of 75 cents..

Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series
22 Sep, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021.

3 Stocks That Could Soar 50% or Better, According to Wall Street
13 Sep, 2021 FinancialContent

All three of these growth stocks are poised to put up big gains once more investors land on the same page as investment bank analysts who follow them.

Amyris Breaks Below 200-Day Moving Average - Notable for AMRS
10 Sep, 2021 FinancialContent

In trading on Friday, shares of Amyris Inc (AMRS) crossed below their 200 day moving average of $13.22, changing hands as low as $13.07 per share. Amyris Inc shares are currently trading down about 4.1% on the day..

Amyris to Present at Two September Investor Conferences
08 Sep, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will present at two upcoming investor conferences and provide a business update.

Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation
07 Sep, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31, it closed the acquisition of Beauty Labs International Ltd. ("Beauty Labs"), a leader in AI technology that provides breakthrough connected consumer experiences to the beauty and wellness community.

Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products
26 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand. Today's launch is the third of three highly anticipated brand launches Amyris is introducing to the market this summer.

Cramer Shares His Thoughts On Amyris, Lam Research And More
24 Aug, 2021 FinancialContent

On CNBC's "Mad Money Lightning Round," Jim Cramer said Beachbody Company Inc (NYSE: BODY) is good, but there are too many ...

Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower
24 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a leading global influencer marketing agency on August 11.

Notable Monday Option Activity: EDIT, LMND, AMRS
23 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Editas Medicine Inc (EDIT), where a total of 13,345 contracts have traded so far, representing approximately 1.3 million underlying shares. That amounts to about 75.2% of EDIT's average daily trading volume over the past month of 1.8 million shares..

Amyris And Rosie Huntington-Whiteley's Rose Inc. Brand Launches Its First Collection Of Beauty Products
23 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Rose Inc., a clean color cosmetics brand. Today's launch is the second of three highly anticipated brand launches Amyris is introducing to the market this summer.

58 Biggest Movers From Friday
23 Aug, 2021 FinancialContent

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell ...

Why Amyris Stock Jumped Today
20 Aug, 2021 FinancialContent

The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.

Amyris Stock Rises on Announcement of Promising Result for COVID Vaccine
20 Aug, 2021 Yahoo! Finance

In vivo results indicate that Amyris' RNA vaccine generates antibodies and provides upper respiratory protection for COVID-19.

Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
20 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).

Notable Two Hundred Day Moving Average Cross - AMRS
19 Aug, 2021 FinancialContent

In trading on Thursday, shares of Amyris Inc (AMRS) crossed below their 200 day moving average of $12.31, changing hands as low as $12.17 per share. Amyris Inc shares are currently trading down about 0.9% on the day..

Amyris Launches Terasana Clinical Clean Skincare Brand
19 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand. Today's launch represents the first of three highly anticipated brand launches Amyris will launch this summer.

Amyris Launches Next Virtual Investor Mini-Series
16 Aug, 2021 Yahoo! Finance

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".

These 10 Standout Stocks Could Be the Next Amazon
16 Aug, 2021 Yahoo! Finance

Companies like Amazon or Visa that can generate double-digit compound growth in revenue and earnings, year after year, are rarities. These smaller candidates could do just that.

Understanding Amyris's Unusual Options Activity
09 Aug, 2021 FinancialContent

Shares of Amyris (NASDAQ:AMRS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved ...

Zymergen's Implosion Makes Amyris a Screaming Buy
09 Aug, 2021 FinancialContent

The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.

Peek Under The Hood: VBK Has 15% Upside
06 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Small-Cap Growth ETF (VBK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $331.01 per unit.

Amyris, Inc (AMRS) is a NASDAQ Common Stock listed in , ,

970x250